NewsFlash Archive

more Events

Subscribe

  • 0%
    0 votes

    Orphan Drugs in Asia 2010: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market

    Monday, March 1, 2010

    DUBLIN -- Research and Markets (http://www.researchandmarkets.com/research/eaee20/orphan_drugs_in_as) has announced the addition of the "Orphan Drugs in Asia 2010: Guidelines and Regulatory Requirements to Help Orphan Drug Products Enter the Asian Market" report to their offeringFollowing the exam

    read more>>

  • 0%
    0 votes

    Targeted Delivery of Losartan Reduces Liver Inflammation and Scarring

    Monday, March 1, 2010

    A recent study found that rats with advanced fibrosis that were administered a short-term dose of losartan-M6PHSA had reduced liver inflammation and fibrosisThose animals treated with oral losartan alone did not experience a similar reduction in disease activity. Results of this study appear in th

    read more>>

  • 0%
    0 votes

    Ghrelin Mitigates Liver Fibrosis in Animal Models, Regulates Human Fibrosis

    Monday, March 1, 2010

    Spanish researchers determined that rats treated with recombinant ghrelin displayed a reduction in liver fibrosisGhrelin, a stomach hormone, reduced the amount of fibrogenic cells by 25% in the treated rodents. Research further showed ghrelin prevented acute liver damage and reduced oxidative stre

    read more>>

  • 0%
    0 votes

    Gene Signature May Improve Colon Cancer Treatment

    Monday, March 1, 2010

    A gene signature, first identified in mouse colon cancer cells, may help identify patients at risk of colon cancer recurrence, according to a recent study by Vanderbilt-Ingram Cancer Center researchersThe findings, published in the March issue of Gastroenterology, could help personalize treatments

    read more>>

  • 0%
    0 votes

    New Cancer Treatment Gives Hope to Lymphoma and Leukemia Patients

    Monday, March 1, 2010

    SCOTTSDALE, Ariz. -- Cancer researchers have high hopes for a new therapy for patients with certain types of lymphoma and leukemiaPCI-32765 is a new drug being assessed in a Phase I clinical trial at the Virginia G. Piper Cancer Center in collaboration with the Clinical Division of the Translation

    read more>>

  • 0%
    0 votes

    Gene Therapy Reverses Effects of Lethal Childhood Muscle Disease in Mice

    Monday, March 1, 2010

    COLUMBUS, Ohio -- Reversing a protein deficiency through gene therapy can correct motor function, restore nerve signals and improve survival in mice that serve as a model for the lethal childhood disorder spinal muscular atrophy, new research showsThis muscle-wasting disease results when a child&r

    read more>>

  • 0%
    0 votes

    NPS Pharmaceuticals Announces Support for Rare Disease Day Observance

    Friday, February 26, 2010

    BEDMINSTER, N.J. -- NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced today its support for the second annual U.S. Rare Disease Day observance on February 28Rare Disease Day aims to call attention

    read more>>

  • 0%
    0 votes

    Brave Teacher's Tribute to Dad

    Friday, February 26, 2010

    A disabled teacher is gearing up for a charity parachute jump in memory of her late fatherJemma Collins is taking the plunge to raise funds for the Jennifer Trust for Spinal Muscular Atrophy (JTSMA) on the one year anniversary of her father's deathJemma of Caernarvon Drive, Clayhall, said: "I was

    read more>>

  • 0%
    0 votes

    Mum Seeks More Rare Disease Support

    Friday, February 26, 2010

    A mother in Cairns is urging the community to support people with rare illnesses, during Rare Disease Day this SundayMeagan Cross's daughter was diagnosed with Angelman Syndrome two years ago, a disease that delays a child's developmentShe says there is not enough community awareness or support s

    read more>>

  • 0%
    0 votes

    Join PNE Stars on Run to Help Charity

    Friday, February 26, 2010

    Runners can join Preston North End players in a charity run this weekendJennifer Lonergan, wife of Lilywhites' goalkeeper Andrew, has arranged the event to raise money for the Royal Manchester Children's Hospital Gem (Genetics, Enzymes, Metabolism) AppealThe charity helped the couple's three-year

    read more>>